Abstract:Antisense therapeutics such as splice-modulating antisense oligonucleotides (ASOs) are promising tools to treat diseases caused by splice-altering intronic variants. However, their testing in animal models is hampered by the generally poor sequence conservation of the intervening sequences between human and other species. Here we aimed to model in the mouse a recurrent, deep-intronic, splice-activating, variant, associated with a severe form of Collagen VI-related muscular dystrophies (COL6-RDs), for the purpose of testing human-ready antisense therapeutics . The variant, c.930+189C>T, creates a donor splice site and inserts a 72-nt-long pseudoexon, which, when translated, acts in a dominant-negative manner, but which can be skipped with ASOs. We created a unique humanized mouse allele (designated as “h”), in which a 1.9 kb of the mouse genomic region encoding the amino-terminus (N-) of the triple helical (TH) domain of collagen α1(VI) was swapped for the human orthologous sequence. In addition, we also created an allele that carries the c.930+189C>T variant on the same humanized knock-in sequence (designated as “h+189T”). We show that in both models, the human exons are spliced seamlessly with the mouse exons to generate a chimeric mouse-human collagen α1(VI) protein. In homozygous mice, the pseudoexon is expressed at levels comparable to those observed in heterozygous patients’ muscle biopsies. While mice do not show any phenotype compared to wild-type animals, and mice have smaller muscle masses and display grip strength deficits detectable as early as 4 weeks of age. The pathogenic h+189T humanized knock-in mouse allele thus recapitulates the pathogenic splicing defects seen in patients’ biopsies and allows testing of human-ready precision antisense therapeutics aimed at skipping the pseudoexon. Given that the N-TH region is a hot-spot for COL6-RD variants, the humanized knock-in mouse model can be utilized as a template to introduce other pathogenic variants. This unique humanized mouse model thus represents a valuable tool for the development of antisense therapeutics for COL6-RDs.

A CRISPR-engineered Swine Model of COL2A1 Deficiency Recapitulates Altered Early Skeletal Developmental Defects in Humans

De Novo Mutation in COL2A1 Leads to Lethal Foetal Skeletal Dysplasia

Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer's Disease

Endoplasmic Reticulum Stress-Unfolding Protein Response-Apoptosis Cascade Causes Chondrodysplasia in a Col2a1 P.gly1170ser Mutated Mouse Model.

CRISPR/Cas9-mediated Correction of MITF Homozygous Point Mutation in a Waardenburg Syndrome 2A Pig Model.

A humanized knock-in mouse recapitulates a deep-intronic splice-activating variant

Two Novel Mutations of COL1A1 in Fetal Genetic Skeletal Dysplasia of Chinese

Genetic engineering a large animal model of human hypophosphatasia in sheep

Generation of CRISPR/Cas9-mediated Gene-Targeted Pigs Via Somatic Cell Nuclear Transfer

Production of gene-edited pigs harboring orthologous human mutations via double cutting by CRISPR/Cas9 with long single-stranded DNAs as homology-directed repair templates by zygote injection

Mutation Analysis of COL1A1 and COL1A2 in Fetuses with Osteogenesis Imperfecta Type II/III

Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling

Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta

Modification of COL1A1 in Autologous Adipose Tissue‐Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta

AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta

CRISPR/Cas9-Mediated Gene Editing in Porcine Models for Medical Research

Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs

Suppressing UPR-dependent Overactivation of FGFR3 Signaling Ameliorates SLC26A2-deficient Chondrodysplasias.

Generation of Pigs with a Belgian Blue Mutation in MSTN Using CRISPR/Cpf1-assisted Ssodn-Mediated Homologous Recombination

Generation of Complement Protein C3 Deficient Pigs by Crispr/Cas9-Mediated Gene Targeting

An exonic splicing enhancer mutation in DUOX2 causes aberrant alternative splicing and severe congenital hypothyroidism in Bama pigs